SCHEMBL19707045

SCHEMBL19707045

CCC[C@@H](O)[C@@H](C)Cc1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 3/20 0.72
CYP2D6 P10635 1/20 0.52
CSNK1E P49674 1/20 0.50
SIGMAR1 Q99720 4/20 0.46
TAAR1 Q96RJ0 4/20 0.45
SLC6A2 P23975 2/20 0.45
MAOA P21397 1/20 0.45
SLC6A4 P31645 1/20 0.45
SLC6A3 Q01959 1/20 0.45
CYP2A6 P11509 1/20 0.45
ADORA2A P29274 1/20 0.45
ADORA1 P30542 1/20 0.45
POLB P06746 1/20 0.44
SLC18A2 Q05940 1/20 0.42
BCHE P06276 1/20 0.42
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC8 Q9BY41 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11613701 0.89 TRPA1 (0.68) TRPA1CYP2D6CSNK1ESIGMAR1TAAR1
Hydrochloric Acid SCHEMBL9346955 0.84 CSNK1E (0.68) TRPA1CYP2D6CSNK1E
Water SCHEMBL9250282 0.84 CSNK1E (0.68) TRPA1CYP2D6CSNK1E
SCHEMBL18456337 0.84 TRPA1 (1.00) TRPA1CYP2D6CSNK1ESIGMAR1TAAR1
SCHEMBL12768230 0.84 TRPA1 (1.00) TRPA1CYP2D6CSNK1ESIGMAR1TAAR1
SCHEMBL3654793 0.84 TRPA1 (0.55) TRPA1CSNK1ESIGMAR1TAAR1SLC6A2
SCHEMBL7760979 0.83 TRPA1 (0.65) TRPA1CYP2D6CSNK1ESIGMAR1TAAR1
SCHEMBL16169480 0.80 TRPA1 (0.71) TRPA1CYP2D6SIGMAR1TAAR1SLC6A2
SCHEMBL11590730 0.79 CSNK1E (0.76) TRPA1CYP2D6CSNK1ESIGMAR1TAAR1
SCHEMBL21852752 0.79 TRPA1 (0.69) TRPA1CYP2D6SIGMAR1TAAR1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170354636-A1 METHODS FOR INHIBITING TUMORS AND DRUG RESISTANCE SEQUOIA PHARMACEUTICALS INC (US) 2017-12-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170354636-A1 METHODS FOR INHIBITING TUMORS AND DRUG RESISTANCE HCCS, CYP2E1, CYP7A1 TRPA1 4850/4885CYP2D6 47/4885CSNK1E 1484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.